Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-278-6 | CAS number: 118-79-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Absortion: 2,4,6-Tribromophenol was rapidly absorbed from the gastro-intestinal tract [Clayton et al., 1981].
The absorption, distribution, and elimination of this substance were examined in male or female Eolzman’s albino rats after a single oral administration at doses from 4.04 to 5.34 mg/kg. This substance was rapidly absorbed in rats. The bulk of the radioactivity (77 %) was readily excreted via urine and 2 to 14 % were eliminated in the feces, within 48 hours. The pharmacokinetics of this substance in rats appeared to follow a one compartment open model system. The rate constant for elimination (Ke) was 0.3 and the half-life in the blood was 2.03 hours. Based on the results of this study, this substance should neither be persistent nor accumulative in mammalian systems [GLCC, 1977]
Key value for chemical safety assessment
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 50
- Absorption rate - inhalation (%):
- 100
Additional information
2,4,6-Tribromophenol is rapidly absorbed from the gastro-intestinal tract and is rapidly excreted via urine and feces.
The acute oral LD50 in rats is 1,486 mg/kg bw. The acute inhalation LC50 in rats is greater than 50,000 mg/m3.
The acute dermal LD50 in rats is greater than 2,000 mg/kg bw.
This substance is considered to be non-irritating to the skin, but irritating to the eye. This substance is considered to be a sensitiser in guinea pigs.
A combined repeated dose toxicity study with the reproduction/developmental toxicity screening test [OECD TG 422] was conducted in SD rats administered by gavage at the doses of 0 (vehicle), 100, 300 and 1,000 mg/kg/day.
At 1,000 mg/kg/day, body weight gain suppression, and increase of absolute and relative liver weight were observed in both sexes and increases of total protein, albumin, A/G and ALP in blood were observed in male rats.
At 300 mg/kg/day, salivation was observed in both sexes and increase in blood creatinine was observed in male rats. The NOAEL for the repeat dose toxicity is considered to be 100 mg/kg/day in rats of both sexes.
In the above described combined repeated dose toxicity study with the reproduction/developmental toxicity screening test [OECD TG 422], SD (Crj: CD) rats received gavage doses of 0 (vehicle), 100, 300 and 1,000 mg/kg/day. No adverse effects were observed on estrous cycle, copulation index, fertility index and duration of gestation period, number of corpora lutea, and delivery findings as well as number of implants, number of total pups and live pups born, implantation index and delivery index in any of the substance-treated groups. Neonatal viability on day 4 of lactation and neonatal body weights on days 0 and 4 of lactation in the 1,000 mg/kg/day group were lower than those in the control group (about 50% for neonatal viability in the treated group). In maternal animals at the same dose, body weight was reduced by about 8 % and liver weight was increased by about 15 %. In conclusion, the oral NOAEL for reproduction/developmental toxicity is considered to be 300 mg/kg/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
